The U.S. Food and Drug Administration (FDA) has issued a report titled "Paving the Way for Personalized Medicine: FDA’s Role in a New Era of Medical Product Development." It outlines the steps FDA has taken to support the development of "tailored medical products," i.e., those "drugs, biologics and medical devices targeted to particular sub-populations together with genetic or other biomarker tests for use in identifying appropriate patients for those treatments." The report also includes a table of select agency guidances that relate to personalized medicine. Citing specific examples, the report illustrates how efforts have been made to streamline the approval process for these therapeutics.